- decreased circulating insulin level / MGI
- increased insulin sensitivity / MGI
- improved glucose tolerance / MGI
- decreased circulating glucose level / MGI
- decreased susceptibility to diet-induced obesity / MGI
- decreased subcutaneous adipose tissue amount / MGI
- abnormal fat cell morphology / MGI
- increased epididymal fat pad weight / MGI
- decreased total body fat amount / MGI
- abnormal T cell activation / MGI
- decreased T cell proliferation / MGI
- decreased T cell apoptosis / MGI
B6.129P2-Mapk8tm1Wag/Kctt
Status | Available to order |
EMMA ID | EM:01772 |
International strain name | B6.129P2-Mapk8tm1Wag/Kctt |
Alternative name | Jnk1-C57Bl6 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Mapk8tm1Wag |
Gene/Transgene symbol | Mapk8 |
Information from provider
Provider | Ingrid Fossar-Larsen |
Provider affiliation | Department of Molecular Cancer Biology, Danish Cancer Society |
Genetic information | The Mapk8 (Jnk1) gene is disrupted by insertion of the lacZ cassette at the first exon. This mutation inactivates all known Mapk8 splicing variants. |
Phenotypic information | No major defects. Defects in T-cell apoptosis and proliferation. Mice are resistant to type 2 diabetes. |
References |
|
Information from EMMA
Archiving centre | Karolinska Institutet, Stockholm, Sweden |
Disease and phenotype information
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- thin epidermis / MGI
- abnormal epidermis stratum basale morphology / MGI
- decreased body length / MGI
- decreased body weight / MGI
- abnormal T cell activation / MGI
- decreased circulating insulin level / MGI
- increased insulin sensitivity / MGI
- abnormal cytokine secretion / MGI
- decreased insulin secretion / MGI
- cardiac fibrosis / MGI
- increased cardiomyocyte apoptosis / MGI
- decreased cardiomyocyte apoptosis / MGI
- increased response of heart to induced stress / MGI
- increased incidence of tumors by chemical induction / MGI
- decreased T cell proliferation / MGI
- decreased cardiac muscle contractility / MGI
- improved glucose tolerance / MGI
- abnormal myocardium layer morphology / MGI
- increased T cell proliferation / MGI
- liver/biliary system phenotype / MGI
- homeostasis/metabolism phenotype / MGI
- decreased percent body fat/body weight / MGI
- decreased circulating glucose level / MGI
- abnormal enzyme/coenzyme activity / MGI
- decreased susceptibility to diet-induced obesity / MGI
- decreased circulating leptin level / MGI
- decreased T cell apoptosis / MGI
- abnormal T-helper 1 cell differentiation / MGI
- decreased subcutaneous adipose tissue amount / MGI
- abnormal fat cell morphology / MGI
- decreased gonadal fat pad weight / MGI
- increased epididymal fat pad weight / MGI
- absent keratohyalin granules / MGI
- decreased total body fat amount / MGI
- increased respiratory quotient / MGI
- decreased food intake / MGI
Literature references
- c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation.;Sabapathy K, Kallunki T, David J P, Graef I, Karin M, Wagner E F, ;2001;The Journal of experimental medicine;193;317-28; 11157052
- A central role for JNK in obesity and insulin resistance.;Hirosumi Jiro, Tuncman Gürol, Chang Lufen, Görgün Cem Z, Uysal K Teoman, Maeda Kazuhisa, Karin Michael, Hotamisligil Gökhan S, ;2002;Nature;420;333-6; 12447443
- JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins.;Chang Lufen, Jones Ying, Ellisman Mark H, Goldstein Lawrence S B, Karin Michael, ;2003;Developmental cell;4;521-33; 12689591
- Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector.;Björkblom Benny, Ostman Nina, Hongisto Vesa, Komarovski Vladislav, Filén Jan-Jonas, Nyman Tuula A, Kallunki Tuula, Courtney Michael J, Coffey Eleanor T, ;2005;The Journal of neuroscience : the official journal of the Society for Neuroscience;25;6350-61; 16000625
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).